Re-Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study.

MLA

Wickham, Maeve E., et al. “Re-Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study.” Pharmacoepidemiology and Drug Safety, vol. 33, no. 9, Sept. 2024, p. e70012. EBSCOhost, https://doi.org/10.1002/pds.70012.

APA

Wickham, M. E., McGrail, K. M., Law, M. R., Cragg, A., & Hohl, C. M. (2024). Re-Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study. Pharmacoepidemiology and Drug Safety, 33(9), e70012. https://doi.org/10.1002/pds.70012

Chicago

Wickham, Maeve E, Kimberlyn M McGrail, Michael R Law, Amber Cragg, and Corinne M Hohl. 2024. “Re-Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study.” Pharmacoepidemiology and Drug Safety 33 (9): e70012. doi:10.1002/pds.70012.